ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) — ACROBAT  

Hypertension and Atrial Fibrillation Clinical Trial

Official title: ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing

Status Recruiting

Clinical Trial Summary

Evaluation of 24-hour antihypertensive effect of long-acting ARB-CCB tablet administrated to hypertensive patients with atrial fibrillation, and comparison of 24-hour antihypertensive effect of long-acting ARB-CCB tablet between morning administration and bedtime administration.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Atrial Fibrillation
• Hypertension
• Hypertension and Atrial Fibrillation

• NCT number: NCT01748253
• Study type: Interventional
• Source: Acrobat Trial Group
• Contact: Shinji Mitoma
• Phone: +81-3-5312-5026
• Email: acrobat-study@sa-tt.co.jp
• Status: Recruiting
• Phase: N/A
• Start date: November 2012